Continuous Glucose Monitoring Devices
Key Details
Estimated Value
£1,418,520,300
Deadline
Not specified
Contract Period
Not specified
Procurement Method
Competitive flexible procedure
CPV Code
33195100 - Monitors
Free SME-fit check
Is this tender for me?
Deterministic score from the published notice — not an AI prediction.
43
out of 100
Challenging for many SMEs
On the published fields alone this looks harder for a typical SME (value, time, or missing SME flag). Exceptions exist — check the notice.
Deterministic score from the published notice only (SME/VCSE flags, value, lots, deadline window, framework). Not a prediction you will win, and not legal or bid advice.
Try another notice on the free SME-fit checker.
Key requirements
Extracted from the notice; check the official documents.
- Estimated value
- £1.4bn£1.7bn including VAT
- Contract period
- 1 Apr 2028 to 31 Mar 2032 (4 years)
- Procedure
- Competitive flexible procedure
- Legal basis
- Procurement Act 2023
- Delivery location (NUTS/ITL)
- UKC (North East), UKD (North West), UKF (East Midlands), UKG (West Midlands), UKH (East of England), UKJ (South East) and 3 more
- CPV codes
- 33195100 Monitors; 33124100 Diagnostic devices
- Suitability (buyer's flag)
- SME-suitable
Description
The proposed contract is for the supply of Continuous Glucose Monitoring (CGM). CGMs are real time glucose tracking system that continuously measures interstitial glucose levels through a small sensor inserted under the skin. The system provides automatic glucose readings , reducing the need for frequent finger prick tests. The key components are sensors, transmitter (if applicable) and display devices.
Suitability
Previously won by
No award has been published for this tender. These are the latest award notices from NHS England for medical equipment & pharmaceuticals.
NHS National Framework for Tafamidis · published 2 Oct 2026
CiplaLarge
£941k · Awarded 29 Sept 2026 · Contract ends 31 May 2028 · Award notice ↗
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets · published 2 Sept 2026
Merck Sharpe & Dohme (UK) LimitedLarge, Orifarm UKSME, Unicorn Pharmaceuticals LtdSME, Lupin Healthcare (UK) LimitedSME
£8.5m (total, shared) · Awarded 12 Aug 2026 · Contract ends 31 Oct 2027 · Award notice ↗
NHS National Generic Pharmaceuticals - Wave 16a · published 1 Sept 2026
Lot 1 - CM/PHG/24/5714/01 Oral (plus non-parenteral) products
ASPIRE PHARMA LIMITEDSME, BROWN & BURK UK LIMITEDSME, CRESCENT PHARMA LIMITEDLarge, DRUGSRUS LIMITEDLarge, ENNOGEN HEALTHCARE INTERNATIONAL LIMITEDLarge, FARMAK PHARMACEUTICALS UK LTDSME, FLYNN PHARMA LIMITEDSME, KENT PHARMA UK LIMITEDLarge, Medreich PLCSME, MERCURY PHARMACEUTICALS LIMITEDLarge and 10 more suppliers
£15.5m (total, shared) · Awarded 27 Aug 2026 · Contract ends 31 May 2030 · Award notice ↗
Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regions
DR REDDY'S LABORATORIES (UK) LIMITEDLarge, Accord UK LtdLarge, AFT Pharma UK LimitedSME, AGB Pharma (UK) LtdSME, Aguettant LimitedSME, Amarox LimitedSME, FONTUS HEALTH LTDSME, AOP Orphan LimitedSME, Arcadia Pharma LimitedSME, ASCEND LABORATORIES (UK) LIMITEDSME and 91 more suppliers
£393.3m (total, shared) · Awarded 27 Aug 2026 · Contract ends 31 Jan 2029 · Award notice ↗
Lot 3 - CM/PHG/24/5714/03 Hospital Only (Housekeeping) product DCE/DSW and DLS/DNE
Accord UK LtdLarge, Amarox LimitedSME, ASCEND LABORATORIES (UK) LIMITEDSME, B. BRAUN MEDICAL LIMITEDLarge, BAXTER HEALTHCARE LIMITEDLarge, BRANCASTER PHARMA LIMITEDSME, BROWN & BURK UK LIMITEDSME, CELIX PHARMA LTDSME, CIPLA (EU) LIMITEDLarge, CLINIGEN HEALTHCARE LIMITEDLarge and 33 more suppliers
£21m (total, shared) · Awarded 27 Aug 2026 · Contract ends 31 May 2028 · Award notice ↗
NHS National Framework for Aripiprazole prolonged release injection · published 25 Aug 2026
Otsuka Pharmaceuticals UK LimitedSME, Perennial Pharma LtdSME, Sun Pharma UK LtdSME
£32.1m (total, shared) · Awarded 14 Aug 2026 · Contract ends 31 Jan 2029 · Award notice ↗
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 · published 21 Jul 2026
ACCORD-UK LTDLarge, AMGEN LIMITEDLarge, AVENTIS PHARMA LIMITED t-a SanofiLarge, BAYER PLCLarge, BIOGEN IDEC LIMITEDLarge, CHUGAI PHARMA LIMITEDSME, CST PHARMA LIMITEDSME, ELI LILLY & COMPANY LTDLarge, GEDEON RICHTER (UK) LIMITEDSME, GLAXOSMITHKLINE UK LIMITEDLarge and 14 more suppliers
£665.4m (total, shared) · Awarded 6 Jul 2026 · Contract ends 31 Aug 2028 · Award notice ↗
BIOGEN IDEC LIMITEDLarge, SANDOZ LIMITEDLarge
£35.3m (total, shared) · Awarded 6 Jul 2026 · Contract ends 31 Aug 2027 · Award notice ↗
All open tenders and award history for NHS England →
From award notices on Find a Tender and Contracts Finder. SME or Large is the size the supplier declared on the notice (or, where it is silent, on its latest notice). Values are as published.